Literature DB >> 18070964

Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1.

Arunasalam Naguleswaran1, Arsenio M Fialho, Anita Chaudhari, Chang Soo Hong, Ananda M Chakrabarty, William J Sullivan.   

Abstract

Some pathogenic bacteria produce factors that have evolved a capacity to neutralize competing microbes. The cupredoxin family protein azurin, produced by Pseudomonas aeruginosa, exhibits a remarkable ability to impede invasion of a number of diverse intracellular pathogens, including the human AIDS virus human immunodeficiency virus type 1 and the protozoan parasite Plasmodium falciparum (which causes malaria). Here we report that azurin and an azurin-like protein (Laz) from gonococci/meningococci have activity against Toxoplasma, an apicomplexan parasite that causes opportunistic infection in immunocompromised individuals. We demonstrate that the mechanism of action for Laz involves interfering with the ability of Toxoplasma to adhere to host cells. Computer structural analysis reveals that azurin shares structural features with the predominant surface antigen SAG1, which is known to play an important role in parasite attachment. Interestingly, azurin also has structural similarities to a monoclonal antibody to SAG1. Surface plasmon resonance binding studies validate that SAG1 interacts strongly with Laz and, to lesser extent, azurin. Moreover, Toxoplasma mutants lacking SAG1 are not as susceptible to the growth-inhibitory effects of Laz. Collectively, our data show that Toxoplasma adhesion can be significantly impaired by Laz, and to some extent by azurin, via interactions with SAG1. These observations indicate that Laz can serve as an important tool in the study of host-pathogen interactions and is worthy of further study for development into potential therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070964      PMCID: PMC2224740          DOI: 10.1128/AAC.01005-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.

Authors:  Anita Chaudhari; Magdy Mahfouz; Arsenio M Fialho; Tohru Yamada; Ana Teresa Granja; Yonghua Zhu; Wataru Hashimoto; Beatrix Schlarb-Ridley; Wonhwa Cho; Tapas K Das Gupta; Ananda M Chakrabarty
Journal:  Biochemistry       Date:  2007-01-24       Impact factor: 3.162

Review 2.  Surprising similarities in structure comparison.

Authors:  J F Gibrat; T Madej; S H Bryant
Journal:  Curr Opin Struct Biol       Date:  1996-06       Impact factor: 6.809

3.  Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes.

Authors:  J M Costa; C Pautas; P Ernault; F Foulet; C Cordonnier; S Bretagne
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

4.  Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.

Authors:  J R Mineo; R McLeod; D Mack; J Smith; I A Khan; K H Ely; L H Kasper
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

5.  Neospora caninum and Toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions.

Authors:  Arunasalam Naguleswaran; Norbert Müller; Andrew Hemphill
Journal:  Exp Parasitol       Date:  2003 Jul-Aug       Impact factor: 2.011

6.  Monoclonal antibodies to Toxoplasma cell membrane surface antigens protect mice from toxoplasmosis.

Authors:  A M Johnson; P J McDonald; S H Neoh
Journal:  J Protozool       Date:  1983-05

7.  Structure of the immunodominant surface antigen from the Toxoplasma gondii SRS superfamily.

Authors:  Xiao-lin He; Michael E Grigg; John C Boothroyd; K Christopher Garcia
Journal:  Nat Struct Biol       Date:  2002-08

8.  Biology of Toxoplasma gondii.

Authors:  S Y Wong; J S Remington
Journal:  AIDS       Date:  1993-03       Impact factor: 4.177

9.  Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction.

Authors:  J L Burg; C M Grover; P Pouletty; J C Boothroyd
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

10.  The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii.

Authors:  Nicolas Rachinel; Dominique Buzoni-Gatel; Chaitali Dutta; Franck J D Mennechet; Souphalone Luangsay; Laurie A Minns; Michael E Grigg; Stanislas Tomavo; John C Boothroyd; Lloyd H Kasper
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

View more
  9 in total

1.  PRMT1 methylates the single Argonaute of Toxoplasma gondii and is important for the recruitment of Tudor nuclease for target RNA cleavage by antisense guide RNA.

Authors:  Alla Musiyenko; Tanmay Majumdar; Joel Andrews; Brian Adams; Sailen Barik
Journal:  Cell Microbiol       Date:  2012-02-28       Impact factor: 3.715

2.  Bacterial azurin in potential cancer therapy.

Authors:  Ananda M Chakrabarty
Journal:  Cell Cycle       Date:  2016-04-22       Impact factor: 4.534

3.  Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses.

Authors:  Wen-Shu Li; Qing-Xin Chen; Ju-Xiu Ye; Zi-Xin Xie; Jun Chen; Li-Fang Zhang
Journal:  Parasitol Res       Date:  2011-03-15       Impact factor: 2.289

4.  Bioengineered bugs, drugs and contentious issues in patenting.

Authors:  Ananda M Chakrabarty
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

5.  Structural studies on Laz, a promiscuous anticancer Neisserial protein.

Authors:  Wataru Hashimoto; Akihito Ochiai; Chang Soo Hong; Kousaku Murata; Ananda M Chakrabarty
Journal:  Bioengineered       Date:  2015-02-25       Impact factor: 3.269

6.  Global Sequence Analysis and Expression of Azurin Gene in Different Clinical Specimens of Burn Patients with Pseudomonas aeruginosa Infection.

Authors:  Hajar Mohammadi Barzelighi; Bita Bakhshi; Bahram Daraei; Hossein Fazeli; Bahram Nasr Esfahani
Journal:  Infect Drug Resist       Date:  2020-07-13       Impact factor: 4.003

7.  Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53.

Authors:  Chuong Nguyen; Van Duy Nguyen
Journal:  Biomed Res Int       Date:  2016-04-30       Impact factor: 3.411

8.  Analysis of antibacterial and antibiofilm activity of purified recombinant Azurin from Pseudomonas aeruginosa.

Authors:  Hajar Mohammadi-Barzelighi; Bahram Nasr-Esfahani; Bita Bakhshi; Bahram Daraei; Sharareh Moghim; Hossein Fazeli
Journal:  Iran J Microbiol       Date:  2019-04

9.  Therapeutic p28 peptide targets essential H1N1 influenza virus proteins: insights from docking and molecular dynamics simulations.

Authors:  Santanu Sasidharan; Vijayakumar Gosu; Donghyun Shin; Subhradip Nath; Timir Tripathi; Prakash Saudagar
Journal:  Mol Divers       Date:  2021-02-11       Impact factor: 3.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.